The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta-analysis

被引:0
作者
Tabesh, Mahtab [1 ,2 ]
Sacre, Julian W. [1 ]
Mehta, Kanika [1 ]
Chen, Lei [1 ]
Sajjadi, Seyeddeh Forough [1 ,3 ]
Magliano, Dianna J. [1 ,3 ]
Shaw, Jonathan E. [1 ,2 ,3 ]
机构
[1] Baker Heart & Diabet Inst, Level 4,99 Commercial Rd, Melbourne, Vic 3004, Australia
[2] La Trobe Univ, Baker Dept Cardiovasc Res Translat & Implementat, Melbourne, Vic, Australia
[3] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
关键词
cardiac dysfunction; cardiovascular disease; diabetes complication; diabetes duration; glycaemic variability; glycated haemoglobin; HbA1c; heart failure; hypoglycaemia; type 2 diabetes mellitus; 3 HBA(1C) VARIABLES; CARDIOVASCULAR-DISEASE; PUBLICATION BIAS; COMPLICATIONS; VARIABILITY; HEMOGLOBIN; MORTALITY; DIAGNOSIS; OUTCOMES; MODEL;
D O I
10.1111/dom.15938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To conduct a systematic review in order to better understand the association of glycaemic risk factors and diabetes duration with risk of heart failure (HF) in individuals with type 2 diabetes (T2D). Methods: We identified longitudinal studies investigating the association of glycaemic factors (glycated haemoglobin [HbA1c], HbA1c variability, and hypoglycaemia) and diabetes duration with HF in individuals with T2D. Hazard ratios and odds ratios were extracted and meta-analysed using a random-effects model where appropriate. Risk of bias assessment was carried out using a modified Newcastle-Ottawa Scale. Egger's test along with the trim-and-fill method were used to assess and account for publication bias. Results: Forty studies representing 4 102 589 people met the inclusion criteria. The risk of developing HF significantly increased by 15% for each percentage point increase in HbA1c, by 2% for each additional year of diabetes duration, and by 43% for having a history of severe hypoglycaemia. Additionally, variability in HbA1c levels was associated with a 20%-26% increased risk of HF for each unit increase in the metrics of variability (HbA1c standard deviation, coefficient of variation, and average successive variability). All included studies scored high in the risk of bias assessment. Egger's test suggested publication bias, with trim-and-fill analyses revealing a significant 14% increased risk of HF per percentage point increase in HbA1c. Conclusions: Glycaemic risk factors and diabetes duration significantly contribute to the heightened risk of HF among individuals with T2D. A reduction in risk of HF is anticipated with better management of glycaemic risk factors.
引用
收藏
页码:5690 / 5700
页数:11
相关论文
共 50 条
  • [41] The effectiveness of goal setting on glycaemic control for people with type 2 diabetes and prediabetes: A systematic review and meta-analysis
    Whitehead, Lisa
    Glass, Courtney
    Coppell, Kirsten
    JOURNAL OF ADVANCED NURSING, 2022, 78 (05) : 1212 - 1227
  • [42] Carbohydrate restriction for glycaemic control in Type 2 diabetes: a systematic review and meta-analysis
    McArdle, P. D.
    Greenfield, S. M.
    Rilstone, S. K.
    Narendran, P.
    Haque, M. S.
    Gill, P. S.
    DIABETIC MEDICINE, 2019, 36 (03) : 335 - 348
  • [43] Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis
    Schwab, Ursula
    Reynolds, Andrew N.
    Sallinen, Taisa
    Rivellese, Angela Albarosa
    Riserus, Ulf
    EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (06) : 3355 - 3363
  • [44] Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes A Systematic Review and Meta-analysis
    Schellenberg, Elizabeth Sumamo
    Dryden, Donna M.
    Vandermeer, Ben
    Ha, Christine
    Korownyk, Christina
    ANNALS OF INTERNAL MEDICINE, 2013, 159 (08) : 543 - +
  • [45] Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis
    Lee, Kai Wei
    Ching, Siew Mooi
    Ramachandran, Vasudevan
    Yee, Anne
    Hoo, Fan Kee
    Chia, Yook Chin
    Sulaiman, Wan Aliaa Wan
    Suppiah, Subapriya
    Mohamed, Mohd Hazmi
    Veettil, Sajesh K.
    BMC PREGNANCY AND CHILDBIRTH, 2018, 18
  • [46] Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes A Network Meta-Analysis
    Kramer, Caroline K.
    Ye, Chang
    Campbell, Sara
    Retnakaran, Ravi
    JACC-HEART FAILURE, 2018, 6 (10) : 823 - 830
  • [47] Liver Aminotransferases and Risk of Incident Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Kunutsor, Setor K.
    Apekey, Tanefa A.
    Walley, John
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (02) : 159 - 171
  • [48] Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis
    Li, Jiyifan
    Zhu, Chenyang
    Liang, Jingru
    Hu, Jiarong
    Liu, Haiyang
    Wang, Zihan
    Guan, Ruifang
    Chow, Junwei
    Yan, Shiwei
    Li, Longzhou
    Ma, Fuyan
    Ma, Guo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] Impact of accelerometer and pedometer use on physical activity and glycaemic control in people with Type 2 diabetes: a systematic review and meta-analysis
    Baskerville, R.
    Ricci-Cabello, I.
    Roberts, N.
    Farmer, A.
    DIABETIC MEDICINE, 2017, 34 (05) : 612 - 620
  • [50] Prevalence and Risk Factors of Cardiac Amyloidosis in Heart Failure: A Systematic Review and Meta-Analysis
    See, Alicia Su Yun
    Ho, Jamie Sin-Ying
    Chan, Mark Y.
    Lim, Yoke Ching
    Yeo, Tiong-Cheng
    Chai, Ping
    Wong, Raymond C. C.
    Lin, Weiqin
    Sia, Ching-Hui
    HEART LUNG AND CIRCULATION, 2022, 31 (11) : 1450 - 1462